"Social separation" among women under 40 years of age diagnosed with breast cancer and carrying a BRCA1 or BRCA2 mutation

Journal of Genetic Counseling

Volumn 15, Issue 3, 2006, Pages 149-162

  Kenen, Regina ^a   Ardern Jones, Audrey ^b   Eeles, Rosalind ^b  

^a The College of New Jersey   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

BRCA1; BRCA2; Early onset breast cancer; Family; Genetic testing; Interpersonal relations emotions; Isolation; Norms; Social context

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO ILLNESS; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; CULTURAL FACTOR; EMOTIONALITY; EXPLORATORY RESEARCH; FAMILY ATTITUDE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; HUMAN RELATION; ONCOGENE; ONSET AGE; OVARY CANCER; QUALITATIVE RESEARCH; SECOND CANCER; SOCIAL INTERACTION; SOCIAL ISOLATION; SOCIAL SEPARATION; TUMOR SUPPRESSOR GENE; UNITED KINGDOM; VERBAL COMMUNICATION;

ADULT; ANXIETY, SEPARATION; BREAST NEOPLASMS; CHILD; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE DETECTION; HUMANS; LONELINESS; MOTHER-CHILD RELATIONS; MUTATION; NUCLEAR FAMILY; SELF CONCEPT; SOCIAL BEHAVIOR; SOCIAL ISOLATION;

EID: 33745597609     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-005-9015-2     Document Type: Article

References (41)

1. Ardern-Jones, A., Kenen, R., & Eeles, R. (2005). Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40. Eur J Cancer Care, 14, 272-281.
2. Beeson, D. (1997). Nuance, complexity, and context: Qualitative methods in genetic counseling research. J Genet Couns, 6, 21-43.
3. Bury, M. R. (1991). The sociology of chronic illness: A review of research and prospects. Sociol Health Illn, 13, 451-468.
4. Bury, M. R. (1982). Chronic illness as biographical disruption. Social Health Illn, 4, 167-182.
5. Camp, D. L., Finlay, W. M. L., & Lyons, E. (2002). Is low self-esteem an inevitable consequence of stigma? An example from women with chronic mental health problems. Soc Sci Med, 55(5), 823-834.
6. Campbell, T. L. (2003). The effectiveness of family interventions for physical disorders. J Marital Fam Ther, 29(2), 263-281.
7. Corbin, J., & Strauss, A. (1988). Unending work and care: Managing chronic illness at home. San Francisco: Jossey-Bass.
8. DiProspero, L. S., Seminsky, M., Honeyford, J., Doan, B., Franssesn, E., Meschino, W., et al. (2001). Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations findings from a focus group and a needs-assessment survey. Can Med Assoc, 1634(7), 1005-1009.
9. Fern, E. F. (2001). Advanced focus group research. Thousand Oaks, CA: Sage.
10. Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., et al. (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet, 62(3), 676-689.
11. Foster, C., Eeles, R., Ardern-Jones, A., Moynihan, C., & Watson, M. (2004). Juggling roles and expectations: Dilemmas faced by women talking to relatives about cancer and genetic testing. Psychol Health, 19(4), 439-455.
12. Foucault, M. (1978). The history of sexuality: An introduction (Vol. 1). New York: Pantheon.
13. Garber, M. (1991). Vested interests. London: Routledge.
14. Glaser, B. (1978). Theoretical sensitivity. Mill Valley, CA: Sociology Press.
15. Hallowell, N. (2000). Reconstructing the body or reconstructing the woman? Problems of prophylactic mastectomy for hereditary breast cancer risk. In L. Potts (Ed.), Ideologies of breast cancer: Feminist perspectives. New York: St. Martin's Press.
16. Hamilton, F., Bowers, B., & Williams, J. (2005). Disclosing genetic test results to family members. J Nurs Scholarsh, 37(1), 18-24.
17. Hochschild, A. (1979). Emotion work, feeling rules and social structure. Am J Sociol, 85, 551-575.
18. Kenen, R., Ardern-Jones, A., & Eeles, R. (2003). Living with chronic risk: Women from hereditary breast/ovarian cancer families (HBOC). Health Risk Soc, 5(3), 315-331.
19. Kenen, R., Ardern-Jones, R., & Eeles, R. (2004). We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer (HBOC). Psychooncology, 13, 335-345.
20. Kenen, R., & Moller, D. (1996). Medical diagnosis and the creation of an emotional stranger, discussion round table. New York City: American Sociological Association Meeting.
21. Krueger, R. A., & Casey, M. A. (2000). Focus groups: A practical guide for applied research. Thousand Oaks, CA: Sage.
22. Lakhani, S., van de Vijver, M., Jacquemier, J., Anderson, T. J., Osin, P. P., McGuffog, L., et al., for the Breast Cancer Linkage Consortium (2002). The pathology of familial breast cancer: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2 and P53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol, 20(9), 2310-2318.
23. Lloyd, S. M., Waston, M., Oaker, G., Sacks, N., Querci della Reovere, U., & Gui, G. (2000). Understanding the experience of prophylactic bilateral mastectomy: A qualitative study of ten women. Psycho-oncology, 6, 473-485.
24. Mathieson, C. M., & Stam, H. J. (1995). Renegotiating identity: Cancer narratives. Social Health Illn, 17, 283-306.
25. Merton, R. K., Fiske, M., & Kendall, P. L. (1990). The focused interview: A manual of problems and procedures (2nd ed.). New York: Free Press.
26. Metcalfe, K. A., Liede, A., Hoodfar, E., Scott, A., Foulkes, W. D., & Narod, S. A. (2000). An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counseling. J Med Genet, 37, 866-874.
27. Morgan, D. L. (1997). Focus groups as qualitative research. Thousand Oaks, CA: Sage.
28. Odets, W. (1995). In the shadow of the epidemic. Durham, NC: Duke University Press.
29. Palacios, J., Honrado, E., Osorio, A., et al. (2003). Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: Differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Clin Cancer Res, 9(10), 3606-3614.
30. Parsons, E., & Atkinson, P. (1992). Lay constructions of genetic risk. Social Health Illn, 14, 437-454.
31. Parsons, T. (1951). The social system. New York: Free Press.
32. Rolland, J. S. (1994). Families, illness & disability: An integrative treatment model. New York: Basic Books.
33. Rolland, J. S., & Williams, J. K. (2005). Toward a biopsychosocial model for 21st century genetics. Fam Process, 44(1), 3-24.
34. Weihs, K., Fisher, L., & Baird, M. (2002). Families, health and behavior: A section of the commissioned report by the committee on health and behavior research, practice and policy. Fam Syst Health, 20(1), 7-46.
35. Roth, J. A. (1963). Timetables: Structuring the passage of time in hospital treatment and other careers. New York: Bobbs-Merrill.
36. Smith, J. A. (1996). Evolving issues for qualitative psychology. In J. T. E. Richardson (Ed.), Handbook of qualitative research methods (pp. 273-285). Leicester, UK: The British Psychological Society.
37. Sowter, H., & Ashworth, R. (2005). BRCA1 and BRCA2 as ovarian cancer susceptibility genes. Carcinogenesis, May 25 (Reprint ahead of print).
38. Struewing, J. P., Hartge, P., & Wacholder, S. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med, 336, 1401-1408.
39. Thompson, D., Easton, D., Eeles, R. A., Breast Cancer Linkage Consortium (2001). Variation in cancer risks by mutation position in BRCA2 mutation carriers. Am J Hum Genet, 68(2), 410-419.
40. Wexler, A. (1995). Mapping fate: A memoir of family, risk, and genetic research. New York: Times Books.
41. Wolf, J. (2004). The information needs of women who have undergone breast reconstruction. Part I. Eur J Oncol Nurs, 8(3), 211-223.